Watchlist Price Alert

NGM Biopharmaceuticals In... (NGM)

NASDAQ: NGM · Real-Time Price · USD

1.54

-0.02 (-1.28%)

At close: Apr 03, 2024, 3:59 PM

NGM Biopharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-142.38M	-162.67M	-120.33M	-102.49M	-42.8M	-493K	-14.16M	-6.92M
Depreciation & Amortization	2.22M	4.04M	6.09M	6.55M	7.61M	7.22M	6.44M	3.53M
Stock-Based Compensation	28.72M	32.38M	26.24M	15.65M	12.98M	9.96M	7.72M	6.02M
Other Working Capital	-20.92M	-23.92M	8.63M	-4.61M	-21.58M	-27.07M	-13.51M	-5.26M
Other Non-Cash Items	-7.37M	2.52M	7.05M	613K	98K	91K	82K	65K
Deferred Income Tax	4.98M	n/a	3.51M	-128K	-1.12M	-799K	244K	1.09M
Change in Working Capital	-18.38M	-20.71M	4.21M	-3.7M	-17.94M	-23.58M	-17.74M	-2.51M
Operating Cash Flow	-132.2M	-144.44M	-73.23M	-83.5M	-41.17M	-7.6M	-17.41M	1.27M
Capital Expenditures	-1.25M	-1.86M	-1.68M	-1.88M	-3.49M	-5.84M	-6.42M	-24.8M
Cash Acquisitions	n/a	-16.18M	69.97M	49.12M	-52.21M	n/a	n/a	n/a
Purchase of Investments	-105.43M	-272.86M	-293.47M	-177.66M	-134.31M	-133.61M	-217.29M	-132.6M
Sales Maturities Of Investments	220.97M	289.04M	223.5M	128.54M	186.52M	178.18M	220.92M	92.64M
Other Investing Acitivies	n/a	16.18M	-69.97M	-49.12M	52.21M	n/a	n/a	60K
Investing Cash Flow	114.29M	14.32M	-71.65M	-51M	48.72M	38.73M	-2.8M	-64.71M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-185K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.77M	54.23M	149.66M	35.54M	180.75M	198K	339K	231K
Financial Cash Flow	1.77M	54.23M	149.66M	35.54M	180.75M	198K	339K	231K
Net Cash Flow	-14.64M	-75.88M	4.78M	-98.96M	188.3M	31.33M	-19.87M	-63.21M
Free Cash Flow	-133.45M	-146.3M	-74.91M	-85.38M	-44.66M	-13.44M	-23.84M	-23.54M